Athersys
ATHX
#10714
Rank
S$1.06 M
Marketcap
S$0.01719
Share price
-33.50%
Change (1 day)
-98.92%
Change (1 year)

Earnings for Athersys (ATHX)

Earnings in 2023 (TTM): -S$56.26 Million

According to Athersys's latest financial reports the company's current earnings are S$0.08 Million. In 2022 the company made an earning of -S$98.06 Million, an increase over its 2021 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Athersys from 2007 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$56.26 Million-42.63%
2022 -S$98.06 Million-11.54%
2021 -S$0.12 Billion11.14%
2020 -S$99.75 Million72.2%
2019 -S$57.92 Million77.29%
2018 -S$32.67 Million-22.91%
2017 -S$42.38 Million111.89%
2016 -S$20.01 Million-8.52%
2015 -S$21.87 Million-40.81%
2014 -S$36.95 Million18.62%
2013 -S$31.15 Million
2011 -S$17.55 Million19.71%
2010 -S$14.66 Million-26.28%
2009 -S$19.89 Million-18.21%
2008 -S$24.31 Million-8.28%
2007 -S$26.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$42.72 B-80,440.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$12.97 B-24,504.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.42 B-21,593.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.80 B-18,536.14%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$28.55 B-53,792.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$11.87 B-22,436.10%๐Ÿ‡บ๐Ÿ‡ธ USA
United States Lime & Minerals
USLM
S$0.21 B-509.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-S$3.52 Billion 6,504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
-S$0.8 Billion 1,401.18%๐Ÿ‡บ๐Ÿ‡ธ USA